IN THE EYE OF THE PATIENT
CELLTIUM strives to deliver curative therapies for neurological disorders. We have ongoing drug discovery programs and preclinical proof-of-concept for gene therapy targeting Charcot-Marie-Tooth diseases.
News & Events
CELLTIUM is seeking for research talent as well as highly-motivated management. Let us know about your brilliant urge to make a real difference.